Should renin-angiotensin-aldosterone system inhibition enablement be a therapeutic target in CKD patients?

Patrick RossignolRajiv Agarwal

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2021)

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
angiotensin ii
newly diagnosed
angiotensin converting enzyme
prognostic factors
patient reported outcomes
patient reported